• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10310
Device Problem Human-Device Interface Problem (2949)
Patient Problem No Patient Involvement (2645)
Event Date 08/16/2018
Event Type  malfunction  
Manufacturer Narrative
Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The phenomenon of bacterial contamination in blood products, especially platelets, is unfortunately known to occur.With current technologies, given the nature of micro-organisms on human skin and the mechanical act of piercing the skin coupled with the fact that platelets must be incubated at room temperature it is not possible to completely eliminate this phenomenon from occurring.Per internal documentation, the devices terumo bct manufactures in lakewood, co to collect, separate and store blood products are terminally sterilized to an sal of < 10-6.Additionally, a sterility assurance system has been designed and employed to ensure this sal will be achieved for every lot of product manufactured.Therefore it may be concluded that in lieu of a catastrophic failure occurring in the manufacturing process, bacterial contamination observed in collected blood products from terumo bct devices is due to the inherit hazard of collecting blood as it relates to bacterial contamination.Root cause: a definitive root cause could not be determined.Possible causes include but are not limited to:- poor phlebotomy venipuncture- post processing lab qc sampling/handling techniques.
 
Event Description
The customer reported that they had a positive culture from a mononuclear cell (mnc) collection product.There was not a transfusion recipient or patient involved at the time of the unit processing,therefore no patient information is reasonably known at the time of the event.The optia collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w collins ave
lakewood, CO 80215
3032392246
MDR Report Key7857445
MDR Text Key119659862
Report Number1722028-2018-00246
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583103108
UDI-Public05020583103108
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K172590
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/01/2020
Device Catalogue Number10310
Device Lot Number1804103430
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 08/16/2018
Initial Date FDA Received09/07/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/10/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-